Richard M. Burwick

Dr. Richard M. Burwick, an associate professor and maternal-fetal medicine expert, discusses the latest advancements in preeclampsia research. He highlights the importance of angiogenic biomarkers and their role in maternal health, including the newly FDA-approved S-FLIT ratio test. The conversation also dives into the implications of antenatal steroids for late preterm deliveries and the impact of low-dose aspirin on neurodevelopment. Burwick emphasizes the need for equitable access to testing and the balance between biomarker data and clinical judgment.